- Report
- August 2019
- 113 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- January 2023
- 120 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- April 2024
- 175 Pages
From €4834EUR$5,000USD£4,152GBP
- Report
- September 2020
- 92 Pages
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- December 2021
- 120 Pages
Global
From €2417EUR$2,500USD£2,076GBP
- Report
- February 2020
- 145 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- August 2022
- 318 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Webinar
- January 2023
- 60 Minutes
Global
- Webinar
- October 2019
- 3 Hours
Global
From €329EUR$340USD£282GBP
- Webinar
- August 2019
- 180 Minutes
Global
- Webinar
- September 2018
- 60 Minutes
Global
€6961EUR$7,200USD£5,979GBP
- Report
- July 2021
- 121 Pages
Global
From €3200EUR$3,546USD£2,845GBP
- Report
- October 2023
- 146 Pages
Global
From €3410EUR$3,528USD£2,929GBP
€4012EUR$4,150USD£3,446GBP
- Report
- March 2023
- 132 Pages
Global
From €918EUR$950USD£789GBP
- Webinar
- 90 Minutes
Global
From €184EUR$190USD£158GBP
- Webinar
- June 2018
- 60 Minutes
Global
From €184EUR$190USD£158GBP
- Report
- February 2024
- 177 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- February 2024
- 181 Pages
Global
From €3480EUR$3,600USD£2,990GBP
- Report
- July 2022
- 358 Pages
Global
From €5888EUR$6,090USD£5,057GBP
The TMF market within the context of Drug Discovery is a rapidly growing sector of the pharmaceutical industry. It is focused on the development of new drugs and therapies to treat a variety of diseases and conditions. The TMF market is composed of a variety of companies, ranging from large pharmaceutical companies to small biotech firms. These companies are involved in the research and development of new drugs, as well as the manufacturing and distribution of existing drugs.
The TMF market is driven by the need for new and improved treatments for a variety of diseases and conditions. Companies in the TMF market are constantly striving to develop new drugs and therapies that can improve the quality of life for patients. This is done through the use of cutting-edge technologies, such as genomics and proteomics, as well as traditional drug discovery methods.
Some of the companies in the TMF market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, and Sanofi. These companies are involved in the research and development of new drugs, as well as the manufacturing and distribution of existing drugs. Additionally, there are a number of smaller biotech firms that are involved in the TMF market, such as Gilead Sciences, Celgene, and Biogen. Show Less Read more